Ampio Pharmaceuticals Inc 's

• AMPE's Stock Performance relative to its Competitors

Verrica Pharmaceuticals Inc Share Performance -5.13% 30 Days

Verrica Pharmaceuticals Inc Profile Verrica Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing medical solutions for dermatological conditions. Their business model revolves around identifying unmet needs in the dermatology market, conducting rigorous clinical research to develop novel therapies, and efficiently bringing these treatments to market through strategic partnerships and collaborations. Verrica Pharmaceuticals aims to enhance patient outcomes by addressing specific dermatological conditions with innovative solutions. More about Verrica Pharmaceuticals Inc 's Market Share

Incyte Corporation Share Performance +48.10% One Year

Incyte Corporation Profile Incyte Corporation is a biopharmaceutical company that primarily focuses on the research, development, and commercialization of innovative medicines targeting oncology and serious inflammatory conditions. Their business model emphasizes robust R&D investments to discover potential drug candidates, often engaging in collaborations with other organizations to enhance their development capabilities. Incyte leverages its extensive intellectual property portfolio to protect and maximize the value of its therapeutic advancements in the market. More about Incyte Corporation's Market Share

Histogen Inc Share Performance +1.18% Over The Past 5 Days

Histogen Inc Profile Histogen Inc operates as a biopharmaceutical company that focuses on developing and commercializing regenerative medicine therapies. Their business model revolves around researching and developing innovative products that stimulate the body's natural regenerative processes to treat various medical conditions and diseases. They aim to bring these therapies to market through partnerships, licensing agreements, and direct sales, providing healthcare solutions through their regenerative medicine technologies. More about Histogen Inc 's Market Share

Gt Biopharma Inc Share Performance -9.09% Over The Past 5 Days

Gt Biopharma Inc Profile Gt Biopharma Inc's business model revolves around developing innovative immunotherapies for the treatment of various cancers. The company focuses on harnessing the power of the immune system to target and eliminate cancer cells through its proprietary technology platform. Gt Biopharma Inc aims to advance its therapies through clinical trials and ultimately commercialize them for the benefit of patients worldwide. More about Gt Biopharma Inc 's Market Share

Fibrobiologics Inc Share Performance -88.95% One Year

Fibrobiologics Inc Profile FibroBiologics develops fibroblast-based therapies targeting chronic diseases and applications related to longevity. More about Fibrobiologics Inc 's Market Share

Sources: Ampio Pharmaceuticals inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 18, 2026 5:33 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Ampio Pharmaceuticals inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.